Ionis Pharmaceuticals Shares Outstanding 2006-2020 | IONS

Ionis Pharmaceuticals shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Ionis Pharmaceuticals shares outstanding for the quarter ending June 30, 2020 were 0.139B, a 0.64% decline year-over-year.
  • Ionis Pharmaceuticals 2019 shares outstanding were 0.143B, a 6.58% increase from 2018.
  • Ionis Pharmaceuticals 2018 shares outstanding were 0.134B, a 6.31% increase from 2017.
  • Ionis Pharmaceuticals 2017 shares outstanding were 0.126B, a 4.27% increase from 2016.
Ionis Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2019 143
2018 134
2017 126
2016 121
2015 120
2014 118
2013 111
2012 101
2011 100
2010 99
2009 98
2008 95
2007 84
2006 74
2005 63
Ionis Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-06-30 139
2020-03-31 139
2019-12-31 143
2019-09-30 143
2019-06-30 140
2019-03-31 142
2018-12-31 134
2018-09-30 137
2018-06-30 129
2018-03-31 125
2017-12-31 126
2017-09-30 124
2017-06-30 124
2017-03-31 125
2016-12-31 121
2016-09-30 123
2016-06-30 121
2016-03-31 121
2015-12-31 120
2015-09-30 120
2015-06-30 128
2015-03-31 119
2014-12-31 118
2014-09-30 118
2014-06-30 118
2014-03-31 117
2013-12-31 111
2013-09-30 115
2013-06-30 109
2013-03-31 102
2012-12-31 101
2012-09-30 101
2012-06-30 100
2012-03-31 100
2011-12-31 100
2011-09-30 100
2011-06-30 100
2011-03-31 100
2010-12-31 99
2010-09-30 99
2010-06-30 99
2010-03-31 99
2009-12-31 98
2009-09-30 98
2009-06-30 98
2009-03-31 98
2008-12-31 95
2008-09-30 100
2008-06-30 95
2008-03-31 91
2007-12-31 84
2007-09-30 84
2007-06-30 83
2007-03-31 82
2006-12-31 74
2006-09-30 74
2006-06-30 73
2006-03-31 72
2005-12-31 63
2005-09-30 64
2005-06-30 58
2005-03-31 58
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.417B $1.123B
Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.486B 42.94
Takeda Pharmaceutical (TAK) Japan $58.483B 10.19
Astellas Pharma (ALPMY) Japan $30.589B 15.50
Eisai (ESALY) Japan $26.024B 21.99
UCB SA (UCBJF) Belgium $23.720B 0.00
Merck (MKGAF) Germany $17.609B 23.09
Catalent (CTLT) United States $13.694B 52.94
Grifols, S.A (GRFS) Spain $12.630B 15.44
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.700B 41.42
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.052B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.828B 11.30
United Therapeutics (UTHR) United States $4.858B 11.23
Arrowhead Pharmaceuticals (ARWR) United States $4.369B 0.00
FibroGen (FGEN) United States $4.076B 0.00
Evotec AG (EVTCY) Germany $3.967B 137.87
Hypermarcas (HYPMY) Brazil $3.914B 14.40
ChemoCentryx (CCXI) United States $3.666B 0.00
Nektar Therapeutics (NKTR) United States $3.587B 0.00
PTC Therapeutics (PTCT) United States $3.351B 0.00
Sage Therapeutics (SAGE) United States $2.613B 0.00
Pacira BioSciences (PCRX) United States $2.594B 68.18
Taro Pharmaceutical Industries (TARO) Israel $2.414B 11.69
Cronos Group (CRON) Canada $2.008B 0.00
Xencor (XNCR) United States $1.910B 0.00
Revolution Medicines (RVMD) United States $1.796B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.786B 0.00
USANA Health Sciences (USNA) United States $1.759B 16.57
Ironwood Pharmaceuticals (IRWD) United States $1.630B 11.37
Indivior (INVVY) United States $1.606B 19.91
Corcept Therapeutics (CORT) United States $1.583B 14.57
Akebia Therapeutics (AKBA) United States $1.523B 0.00
Heron Therapeutics (HRTX) United States $1.439B 0.00
Zogenix (ZGNX) United States $1.376B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.280B 12.20
Karyopharm Therapeutics (KPTI) United States $1.114B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.075B 0.00
Translate Bio (TBIO) United States $1.069B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.995B 619.63
VAXART, INC (VXRT) United States $0.993B 0.00
Esperion Therapeutics (ESPR) United States $0.924B 0.00
Tilray (TLRY) Canada $0.880B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.812B 0.00
Altimmune (ALT) United States $0.780B 0.00
Trillium Therapeutics (TRIL) Canada $0.754B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
Endo (ENDP) Ireland $0.717B 1.06
ImmunoGen (IMGN) United States $0.669B 0.00
Collegium Pharmaceutical (COLL) United States $0.619B 0.00
Flexion Therapeutics (FLXN) United States $0.604B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.599B 0.00
Molecular Templates (MTEM) United States $0.590B 0.00
Aerie Pharmaceuticals (AERI) United States $0.576B 0.00
Siga Technologies (SIGA) United States $0.566B 60.42
Radius Health (RDUS) United States $0.562B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.551B 0.00
Ocular Therapeutix (OCUL) United States $0.508B 0.00
Ardelyx (ARDX) United States $0.507B 0.00
Innate Pharma SA (IPHYF) France $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.503B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.491B 24.47
DURECT (DRRX) United States $0.461B 0.00
Organogenesis Holdings (ORGO) United States $0.429B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.424B 0.00
TherapeuticsMD (TXMD) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.353B 8.74
IMV INC (IMV) Canada $0.316B 0.00
Heat Biologics (HTBX) United States $0.312B 0.00
OptiNose (OPTN) United States $0.312B 0.00
Harpoon Therapeutics (HARP) United States $0.311B 0.00
MEI Pharma (MEIP) United States $0.305B 0.00
Concert Pharmaceuticals (CNCE) United States $0.302B 0.00
PROFOUND MEDICL (PROF) Canada $0.301B 0.00
Calithera Biosciences (CALA) United States $0.301B 0.00
Redhill Biopharma (RDHL) Israel $0.295B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.289B 0.00
Rafael Holdings (RFL) United States $0.281B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.266B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.45
CASI Pharmaceuticals (CASI) United States $0.238B 0.00
Nivalis Therapeutics (ALPN) United States $0.223B 0.00
Aquestive Therapeutics (AQST) United States $0.223B 0.00
KalVista Pharmaceuticals (KALV) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.220B 21.71
Taiwan Liposome (TLC) Taiwan $0.190B 0.00
Onconova Therapeutics (ONTX) United States $0.181B 0.00
Xeris Pharmaceuticals (XERS) United States $0.170B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
Jounce Therapeutics (JNCE) United States $0.164B 7.77
Otonomy (OTIC) United States $0.163B 0.00
Lipocine (LPCN) United States $0.136B 0.00
Champions Oncology (CSBR) United States $0.120B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.112B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
India Globalization Capital (IGC) United States $0.105B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.102B 0.00
Hemispherx BioPharma (AIM) United States $0.101B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.101B 0.00
Biomerica (BMRA) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
MediWound (MDWD) Israel $0.094B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.086B 0.00
Addex Therapeutics (ADXN) Switzerland $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.075B 0.00
Sundial Growers (SNDL) Canada $0.074B 0.00
Recro Pharma (REPH) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
PolarityTE (PTE) United States $0.057B 0.00
GTx (ONCT) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Natural Alternatives (NAII) United States $0.048B 0.00
AgeX Therapeutics (AGE) United States $0.046B 0.00
IsoRay (ISR) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Novan (NOVN) United States $0.044B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.07
Bellicum Pharmaceuticals (BLCM) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ProPhase Labs (PRPH) United States $0.032B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
Vical (BBI) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 21.31
Flex Pharma (SLRX) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00